4/8
04:01 pm
kzr
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
3/14
04:21 pm
kzr
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/14
04:01 pm
kzr
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Low
Report
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
3/8
04:05 pm
kzr
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2/28
04:01 pm
kzr
Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
Low
Report
Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
2/26
06:30 pm
kzr
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Medium
Report
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
2/26
06:18 pm
kzr
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis [Yahoo! Finance]
Medium
Report
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis [Yahoo! Finance]
2/26
06:14 pm
kzr
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Low
Report
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
3/14/2024
04:01 pm
kzr
kezar life sciences, inc.
MISS
Report
-1.1%
kezar life sciences, inc.
11/13/2023
04:01 pm
kzr
kezar life sciences, inc.
BEAT
Report
7.6%
kezar life sciences, inc.
8/10/2023
04:01 pm
kzr
kezar life sciences, inc.
MISS
Report
-26.3%
kezar life sciences, inc.
5/11/2023
04:01 pm
kzr
kezar life sciences, inc.
MISS
Report
0.8%
kezar life sciences, inc.
4/16
04:19 pm
kzr
Form PRE 14A Kezar Life Sciences, For: Apr 16
Medium
Report
Form PRE 14A Kezar Life Sciences, For: Apr 16
3/22
04:06 pm
kzr
Form 424B5 Kezar Life Sciences,
Medium
Report
Form 424B5 Kezar Life Sciences,
3/14
04:34 pm
kzr
Form S-8 Kezar Life Sciences,
Low
Report
Form S-8 Kezar Life Sciences,
3/14
04:17 pm
kzr
Form 10-K Kezar Life Sciences, For: Dec 31
Medium
Report
Form 10-K Kezar Life Sciences, For: Dec 31
3/14
04:05 pm
kzr
Form 8-K Kezar Life Sciences, For: Mar 14
Medium
Report
Form 8-K Kezar Life Sciences, For: Mar 14
2/14
06:48 pm
kzr
Form SC 13G/A Kezar Life Sciences, Filed by: ORBIMED ADVISORS LLC
Low
Report
Form SC 13G/A Kezar Life Sciences, Filed by: ORBIMED ADVISORS LLC
2/14
06:44 pm
kzr
Form SC 13G Kezar Life Sciences, Filed by: BARCLAYS PLC
Low
Report
Form SC 13G Kezar Life Sciences, Filed by: BARCLAYS PLC
2/14
06:50 am
kzr
Form SC 13G/A Kezar Life Sciences, Filed by: Avidity Partners Management LP
Medium
Report
Form SC 13G/A Kezar Life Sciences, Filed by: Avidity Partners Management LP
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register